Literature DB >> 11090487

Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.

N Kitaichi1, S Kotake, Y Mizue, H Matsuda, K Onoé, J Nishihira.   

Abstract

AIMS: To determine whether macrophage migration inhibitory factor (MIF) levels were increased in sera of the patients with iridocyclitis.
METHODS: Sera were obtained from 41 patients with acute iridocyclitis, 13 patients with chronic iridocyclitis, and 44 healthy control subjects. MIF levels were determined by a human MIF ELISA.
RESULTS: The average levels of MIF in the sera of patients with both acute and chronic iridocyclitis were significantly higher than that of healthy subjects.
CONCLUSION: Uveitis induces the elevation of serum MIF, which may affect various inflammatory symptoms in uveitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090487      PMCID: PMC1723331          DOI: 10.1136/bjo.84.12.1423

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.

Authors:  N Kitaichi; A Matsuda; S Kotake; K Namba; Y Tagawa; Y Sasamoto; K Ogasawara; K Iwabuchi; K Onoé; H Matsuda; J Nishihira
Journal:  Curr Eye Res       Date:  2000-02       Impact factor: 2.424

2.  The role of cytokines in ocular inflammation.

Authors:  A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

3.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

Authors:  M Bacher; C N Metz; T Calandra; K Mayer; J Chesney; M Lohoff; D Gemsa; T Donnelly; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.

Authors:  T Shimizu; R Abe; A Ohkawara; J Nishihira
Journal:  J Allergy Clin Immunol       Date:  1999-09       Impact factor: 10.793

5.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

6.  Uveitis and systemic disease.

Authors:  A Rothova; H J Buitenhuis; C Meenken; C J Brinkman; A Linssen; C Alberts; L Luyendijk; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

7.  Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.

Authors:  A B Beckingsale; J Davies; J M Gibson; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

8.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

9.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

Review 10.  Cytokines and uveitis, a review.

Authors:  A F De Vos; R Hoekzema; A Kijlstra
Journal:  Curr Eye Res       Date:  1992-06       Impact factor: 2.424

View more
  7 in total

1.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

2.  Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.

Authors:  Nobuyoshi Kitaichi; Tadamichi Shimizu; Ayumi Honda; Riichiro Abe; Kazuhiro Ohgami; Kenji Shiratori; Hiroshi Shimizu; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

3.  Macrophage Migration Inhibitory Factor -173GC Variant Might Increase the Risk of Behçet's Disease.

Authors:  Ayse Feyda Nursal; Serbulent Yigit; Ercan Tural; Goknur Kalkan; Mehmet Kemal Tumer; Akin Tekcan
Journal:  Med Princ Pract       Date:  2018-04-18       Impact factor: 1.927

4.  Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Mizuki Kitamura; Kenichi Namba; Susumu Ishida; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

5.  Increase of KL-6 in sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Satoshi Kotake; Hitoshi Shibuya; Yukiho Yamada; Hitoshi Chiba; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

6.  MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment.

Authors:  Bongsu Kim; Rania Kusibati; Tyler Heisler-Taylor; Dimosthenis Mantopoulos; Jiaxi Ding; Mohamed H Abdel-Rahman; Abhay R Satoskar; Jonathan P Godbout; Sanjoy K Bhattacharya; Colleen M Cebulla
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 7.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.